Bicocca Open Archive

Logo unimib boa
FUMAGALLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.152
AS - Asia 4.793
EU - Europa 3.651
Continente sconosciuto - Info sul continente non disponibili 797
SA - Sud America 659
AF - Africa 113
OC - Oceania 28
Totale 20.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.527
SG - Singapore 1.683
CN - Cina 1.027
IT - Italia 916
VN - Vietnam 675
HK - Hong Kong 612
RU - Federazione Russa 560
CA - Canada 529
DE - Germania 509
BR - Brasile 483
SE - Svezia 452
GB - Regno Unito 294
IE - Irlanda 270
FR - Francia 168
IN - India 159
BD - Bangladesh 122
KR - Corea 90
UA - Ucraina 83
ID - Indonesia 76
TR - Turchia 71
AR - Argentina 68
FI - Finlandia 68
DK - Danimarca 67
JP - Giappone 49
NL - Olanda 45
AT - Austria 38
ZA - Sudafrica 38
LT - Lituania 37
MX - Messico 35
IQ - Iraq 33
CO - Colombia 28
ES - Italia 27
PL - Polonia 27
SA - Arabia Saudita 27
BE - Belgio 24
EC - Ecuador 24
PK - Pakistan 24
AU - Australia 23
PH - Filippine 22
EG - Egitto 19
VE - Venezuela 17
CH - Svizzera 16
PY - Paraguay 14
ET - Etiopia 13
KZ - Kazakistan 12
MY - Malesia 12
IR - Iran 11
UZ - Uzbekistan 11
TN - Tunisia 10
JO - Giordania 9
TW - Taiwan 9
CR - Costa Rica 8
RO - Romania 8
UY - Uruguay 8
CL - Cile 7
HN - Honduras 7
HR - Croazia 7
IL - Israele 7
JM - Giamaica 7
MA - Marocco 7
NP - Nepal 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
PR - Porto Rico 6
SV - El Salvador 6
TH - Thailandia 6
BG - Bulgaria 5
BO - Bolivia 5
EU - Europa 5
GT - Guatemala 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
GR - Grecia 4
KG - Kirghizistan 4
LY - Libia 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
KE - Kenya 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GY - Guiana 2
LC - Santa Lucia 2
MM - Myanmar 2
MU - Mauritius 2
NO - Norvegia 2
Totale 19.381
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.897
Singapore 1.035
Ashburn 911
San Jose 665
Dallas 615
Hong Kong 590
Toronto 364
Milan 361
Wilmington 352
Chandler 323
Council Bluffs 318
Frankfurt am Main 289
Dublin 262
Dearborn 237
New York 204
Los Angeles 202
Woodbridge 187
Ho Chi Minh City 176
Santa Clara 175
Houston 160
Hanoi 144
Fairfield 139
Beijing 137
Princeton 135
Chicago 122
Nanjing 113
Boardman 105
Jacksonville 92
The Dalles 77
Seattle 74
Columbus 67
Guangzhou 67
Moscow 65
Rome 64
Lauterbourg 63
Seoul 63
Buffalo 54
Jakarta 53
Shanghai 50
Basingstoke 46
Nanchang 42
Orem 42
Dong Ket 41
Cambridge 40
São Paulo 40
Helsinki 37
Montreal 34
Atlanta 33
Lawrence 32
Phoenix 32
Munich 31
Vienna 31
Vilnius 30
Shenyang 29
Brooklyn 27
Da Nang 27
Altamura 26
Denver 25
Hangzhou 25
Chennai 24
Hefei 24
Zhengzhou 24
London 23
Pune 22
Shangdi 21
Tokyo 21
Haiphong 20
Jinan 20
Brussels 19
Ottawa 19
Rio de Janeiro 19
Warsaw 19
Manchester 18
Portland 18
Sacramento 18
San Diego 18
Kunming 17
Sydney 17
Andover 16
Baghdad 16
Changsha 16
Tianjin 16
Fremont 15
Boston 14
Falls Church 14
Johannesburg 14
Kent 14
Kocaeli 14
Mainz 14
Poplar 14
Stockholm 14
Washington 14
Addis Ababa 13
Belo Horizonte 13
Charlotte 13
Redondo Beach 13
San Francisco 13
Dhaka 12
Edmonton 12
Ha Long 12
Totale 12.364
Salva come PNG Salva come JPEG
Nome #
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 544
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 506
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 490
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 462
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 449
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 440
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 427
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 415
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 415
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 410
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 391
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 367
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 360
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 357
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 355
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 355
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 351
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 334
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 331
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 328
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 327
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 324
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 319
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 318
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 309
Multimodal experimental approach to the study of human neurological diseases 301
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 297
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 297
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 296
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 294
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 289
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 280
Genetic factors influencing the development of vincristine-induced neurotoxicity 274
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 272
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 267
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 263
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 261
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 252
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 251
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 247
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 245
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 244
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 240
In vitro neurotoxicity of new promising metal-based anticancer complexes 236
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 235
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 235
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 234
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 233
Pharmacokinetics of IVIg in Wistar rats 232
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 232
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 229
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 229
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 228
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 225
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 225
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 222
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 220
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 219
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 214
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 203
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 202
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 199
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 198
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 194
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 185
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 183
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 178
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 154
Blood NfL as a potential axonal damage marker in different CIPN rat models. 154
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 141
Totale 20.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022575 0 0 0 0 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20267.116 754 464 855 581 633 388 1.070 314 530 556 516 455
2026/20271.998 167 254 727 774 76 0 0 0 0 0 0 0
Totale 20.193